Developed on a mucosal drug delivery platform, the semaglutide nasal spray offers several potential advantages: Avoids first-pass metabolism, potentially improving bioavailability Non-invasive administration, significantly enhancing patient adherence Convenient and self-administered, supporting long-term disease management As competition in the GLP-1 space intensifies across injectable and oral formulations, innovation in drug delivery is emerging as a new differentiation strategy
Manski-Nankervis JA, Furler J, ONeal D, Ginnivan L, Thuraisingam S, Blackberry I (2017) Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial
Anti-emetic and emetic effects of erythromycin in Suncus murinus: role of vagal nerve activation, gastric motility stimulation and motilin receptors
A 2A R can also interact with dopamine D 2 R and reduce the expression of D 2 R (Figure 1) [8,9]